Drawing for PIVTRAK

USPTO serial 79286276

PIVTRAK

Reviewed by CopyMark Law Group

Status 401
Filing date
Status date
Registration date
—
Examiner
KEELEY, ALISON REBECCA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PIVTRAK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the diagnosis and treatment of oncological diseases and disorders; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of oncological diseases; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals to treat cancerSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 11, 2020DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Oct 10, 2020DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 11, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 11, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 7, 2020GPNXNOTIFICATION PROCESSED BY IB—
Jul 22, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 22, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 22, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 8, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 5, 2020DOCKASSIGNED TO EXAMINER—
Jun 29, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 29, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 29, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jun 29, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 29, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 29, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 2, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
May 29, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 28, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance